Abstract:Choroidal neovascularization (CNV) is the leading cause of vision loss in many blinding diseases, but current antiangiogenic therapies with invasively intravitreal injection suffer from poor patient compliance and a rate of devastating ocular complications. Here, we develop an alternative antiangiogenic agent based on hybrid cell-membrane-cloaked nanoparticles for noninvasively targeted treatment of CNV. The retinal endotheliocyte membrane coating provides as-fabricated nanoagents with homotypic targeting capability and binding ability to the vascular endothelial growth factor. The fusion of red blood cell membranes protects the hybrid membrane-coated nanoparticles from phagocytosis by macrophages. In a laser-induced wet age-related macular degeneration mouse model, a significantly enhanced accumulation is observed in CNV regions after intravenous delivery of the hybrid membrane-coated nanoparticles. Moreover, an excellent therapeutic efficacy is achieved in reducing the leakage and area of CNV. Overall, the biomimetic antiangiogenic nanoagents provide an effective approach for noninvasive treatment of CNV.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c00680?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c00680</a>.Confirmation of complete hybrid membrane coating onto PLGA nanoparticle cores (Figure S1); long-term stability of [RBC-REC]NPs (Figure S2); self-recognition capability of RECNPs and [RBC-REC]NPs in vitro (Figure S3); targeting affinity to angiogenic endothelial cells in vitro (Figure S4); macrophage uptake of nanoparticles in vitro (Figure S5); biodistribution of nanoparticles in vivo (Figure S6); representative fundus photographs in the day 7 (Figure S7); active-targeting capability of [RBC-REC]NPs in CNV (Figure S8); ability of [RBC-REC]NPs in suppressing endothelial cell migration in vitro (Figure S9); cytotoxic assessment to different ocular cells (Figure S10); biosafety assessment of as-fabricated nanoparticles (Figure S11) (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c00680/suppl_file/nn1c00680_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A drug delivery system of HIF-1α siRNA nanoparticles loaded by mesenchymal stem cells on choroidal neovascularization

Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic

Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells.

Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy.

C176-loaded and Phosphatidylserine-Modified Nanoparticles Treat Retinal Neovascularization by Promoting M2 Macrophage Polarization

Targeted Noninvasive Treatment of Choroidal Neovascularization by Hybrid Cell-Membrane-Cloaked Biomimetic Nanoparticles

Sustained Release of MiR-217 Inhibitor by Nanoparticles Facilitates MSC-Mediated Attenuation of Neointimal Hyperplasia After Vascular Injury

MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization

A Lipid Nanoparticle System Improves Sirna Efficacy in Rpe Cells and A Laser-Induced Murine Cnv Model

Nanovector-based Prolyl Hydroxylase Domain 2 Silencing System Enhances the Efficiency of Stem Cell Transplantation for Infarcted Myocardium Repair.

Targeted Long-term Noninvasive Treatment of Choroidal Neovascularization by Biodegradable Nanoparticles

A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma

Intravenous anti-VEGF agents with RGD peptide-targeted core cross-linked star (CCS) polymers modified with indocyanine green for imaging and treatment of laser-induced choroidal neovascularization

The effect of lncRNA MIR155HG-modified MSCs and exosome delivery to synergistically attenuate vein graft intimal hyperplasia

Tumor specific delivery with redox-triggered mesoporous silica nanoparticles inducing neovascularization suppression and vascular normalization

Reactive Oxygen Species─Responsive Lipid Nanoparticles for Effective RNAi and Corneal Neovascularization Therapy

CT/NIRF dual-modal imaging tracking and therapeutic efficacy of transplanted mesenchymal stem cells labeled with Au nanoparticles in silica-induced pulmonary fibrosis

Precisely targeted drug delivery by mesenchymal stem cells-based biomimetic liposomes to cerebral ischemia-reperfusion injured hemisphere

A nitric oxide-releasing hydrogel for enhancing the therapeutic effects of mesenchymal stem cell therapy for hindlimb ischemia

Nanoparticles and Mesenchymal Stem Cell (MSC) Therapy for Cancer Treatment: Focus on Nanocarriers and a si-RNA CXCR4 Chemokine Blocker as Strategies for Tumor Eradication In Vitro and In Vivo

Novel vascular endothelial growth factor gene delivery system-manipulated mesenchymal stem cells repair infarcted myocardium.